InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: PGG76109 post# 92022

Wednesday, 09/12/2012 5:38:34 PM

Wednesday, September 12, 2012 5:38:34 PM

Post# of 346150
Genentech has a licensing deal with Peregrine for some technology involved in
production of antibodies for the PS-imaging platform. Potentially Peregrine will have
to pay Genentech $5 million. There really isn't anything else there. It is chicken feed.
I was just thinking that a deal with Genentech, which is a subsidiary of Roche, would
mean that the future payments could be eliminated, but as I said it is small change if
bavi is approved. I know Genentech has a state-of-the-art facility in Vacaville, CA for
producing tons of antibodies which could come in handy some day.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News